STAT3 Decoy Oligodeoxynucleotides Suppress Liver Inflammation and Fibrosis in Liver Cancer Cells and a DDC-Induced Liver Injury Mouse Model
Molecules · 2024
DOI: 10.3390/molecules29030593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Hye Jin Choi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, School of Medicine, Daegu Catholic University, Daegu 42472, Republic of Korea. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Chronic, Hepatitis, Liver Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Daegu Catholic University Medical Center.
Abstract (Originalsprache)
Liver damage caused by various factors results in fibrosis and inflammation, leading to cirrhosis and cancer. Fibrosis results in the accumulation of extracellular matrix components. The role of STAT proteins in mediating liver inflammation and fibrosis has been well documented; however, approved therapies targeting STAT3 inhibition against liver disease are lacking. This study investigated the anti-fibrotic and anti-inflammatory effects of STAT3 decoy oligodeoxynucleotides (ODN) in hepatocytes and liver fibrosis mouse models. STAT3 decoy ODN were delivered into cells using liposomes and hydrodynamic tail vein injection into 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-fed mice in which liver injury was induced. STAT3 target gene expression changes were verified using qPCR and Western blotting. Liver tissue fibrosis and bile duct proliferation were assessed in animal experiments using staining techniques, and macrophage and inflammatory cytokine distribution was verified using immunohistochemistry. STAT3 decoy ODN reduced fibrosis and inflammatory factors in liver cancer cell lines and DDC-induced liver injury mouse model. These results suggest that STAT3 decoy ODN may effectively treat liver fibrosis and must be clinically investigated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, School of Medicine, Daegu Catholic University, Daegu 42472, Republic of Korea.
- Seoul Clinical Laboratories of Daegu, Daegu 41238, Republic of Korea.
- Department of Radiology, School of Medicine, Daegu Catholic University, Daegu 42472, Republic of Korea.
- Department of Pathology, School of Medicine, Daegu Catholic University, Daegu 42472, Republic of Korea.
- Department of Internal Medicine, School of Medicine, Daegu Catholic University, Daegu 42472, Republic of Korea.
ORCID-Profile: Hye Jin Choi, Young-Ah Kim, Junghwa Ryu, Kwan-Kyu Park, Sun-Jae Lee, Byung Seok Kim, Joo Dong Kim
Förderung
- Daegu Catholic University Medical Center
Zitieren
APA
Choi, H. J., Kim, Y. A., Ryu, J., Park, K. K., Lee, S. J., Kim, B. S., Song, J. E., & Kim, J. D. (2024). STAT3 Decoy Oligodeoxynucleotides Suppress Liver Inflammation and Fibrosis in Liver Cancer Cells and a DDC-Induced Liver Injury Mouse Model. Molecules. https://doi.org/10.3390/molecules29030593
Vancouver
Choi HJ, Kim YA, Ryu J, Park KK, Lee SJ, Kim BS, et al. STAT3 Decoy Oligodeoxynucleotides Suppress Liver Inflammation and Fibrosis in Liver Cancer Cells and a DDC-Induced Liver Injury Mouse Model. Molecules. 2024. doi:10.3390/molecules29030593
BibTeX
@article{Choi2024,
author = {Choi, Hye Jin and Kim, Young-Ah and Ryu, Junghwa and Park, Kwan-Kyu and Lee, Sun-Jae and Kim, Byung Seok and Song, Jeong-En and Kim, Joo Dong},
title = {STAT3 Decoy Oligodeoxynucleotides Suppress Liver Inflammation and Fibrosis in Liver Cancer Cells and a DDC-Induced Liver Injury Mouse Model},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29030593}
}
EUVIMED